Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition
Authors
Keywords
-
Journal
Science Advances
Volume 7, Issue 47, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-11-18
DOI
10.1126/sciadv.abk1023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blockade of 6-phosphogluconate dehydrogenase generates CD8+ effector T cells with enhanced anti-tumor function
- (2021) Saeed Daneshmandi et al. Cell Reports
- Serine Catabolism Feeds NADH when Respiration Is Impaired
- (2020) Lifeng Yang et al. Cell Metabolism
- A small molecule G6PD inhibitor reveals immune dependence on pentose phosphate pathway
- (2020) Jonathan M. Ghergurovich et al. Nature Chemical Biology
- SynergyFinder 2.0: visual analytics of multi-drug combination synergies
- (2020) Aleksandr Ianevski et al. NUCLEIC ACIDS RESEARCH
- Oxidative Stress in Cancer
- (2020) John D. Hayes et al. CANCER CELL
- Glucose-6-phosphate dehydrogenase is not essential for K-Ras-driven tumor growth or metastasis
- (2020) Jonathan M. Ghergurovich et al. CANCER RESEARCH
- KEAP1/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition
- (2020) Michael S Binkley et al. Cancer Discovery
- Upregulation of Antioxidant Capacity and Nucleotide Precursor Availability Suffices for Oncogenic Transformation
- (2020) Yang Zhang et al. Cell Metabolism
- Functional Genomics In Vivo Reveal Metabolic Dependencies of Pancreatic Cancer Cells
- (2020) Xiphias Ge Zhu et al. Cell Metabolism
- LKB1 and KEAP1/NRF2 pathways cooperatively promote metabolic reprogramming with enhanced glutamine dependence in KRAS-mutant lung adenocarcinoma
- (2019) Ana Galan-Cobo et al. CANCER RESEARCH
- Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1
- (2019) Luca Lignitto et al. CELL
- Mutations in the KEAP1-NFE2L2 pathway define a molecular subset of rapidly progressing lung adenocarcinoma
- (2019) Frauke Goeman et al. Journal of Thoracic Oncology
- Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma
- (2019) Sarah A. Best et al. Nature Communications
- Activation of Oxidative Stress Response in Cancer Generates a Druggable Dependency on Exogenous Non-essential Amino Acids
- (2019) Sarah E. LeBoeuf et al. Cell Metabolism
- Extraction and Quantitation of Nicotinamide Adenine Dinucleotide Redox Cofactors
- (2018) Wenyun Lu et al. ANTIOXIDANTS & REDOX SIGNALING
- Metabolomics and Isotope Tracing
- (2018) Cholsoon Jang et al. CELL
- Clinical and Pathological Characteristics ofKEAP1- andNFE2L2-Mutated Non–Small Cell Lung Carcinoma (NSCLC)
- (2018) Rieke Frank et al. CLINICAL CANCER RESEARCH
- Peak Annotation and Verification Engine for Untargeted LC–MS Metabolomics
- (2018) Lin Wang et al. ANALYTICAL CHEMISTRY
- Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
- (2018) Razvan Cristescu et al. SCIENCE
- Chemical Basis for Deuterium Labeling of Fat and NADPH
- (2017) Zhaoyue Zhang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
- (2017) Rodrigo Romero et al. NATURE MEDICINE
- Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma
- (2017) Federico Pio Fabrizio et al. Oncotarget
- Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer
- (2017) Volkan I Sayin et al. eLife
- QuPath: Open source software for digital pathology image analysis
- (2017) Peter Bankhead et al. Scientific Reports
- Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer
- (2016) Shawn M. Davidson et al. Cell Metabolism
- Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery
- (2016) Thomas G. Davies et al. JOURNAL OF MEDICINAL CHEMISTRY
- Malic enzyme tracers reveal hypoxia-induced switch in adipocyte NADPH pathway usage
- (2016) Ling Liu et al. Nature Chemical Biology
- A Modular Assembly Platform for Rapid Generation of DNA Constructs
- (2016) Elliot H. Akama-Garren et al. Scientific Reports
- Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers
- (2016) Leonard D. Goldstein et al. Cell Reports
- An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis
- (2015) Kıvanç Birsoy et al. CELL
- NRF2 regulates serine biosynthesis in non–small cell lung cancer
- (2015) Gina M DeNicola et al. NATURE GENETICS
- Rapid and efficient one-step generation of paired gRNA CRISPR-Cas9 libraries
- (2015) Joana A. Vidigal et al. Nature Communications
- Tracing Compartmentalized NADPH Metabolism in the Cytosol and Mitochondria of Mammalian Cells
- (2014) Caroline A. Lewis et al. MOLECULAR CELL
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Rapid modelling of cooperating genetic events in cancer through somatic genome editing
- (2014) Francisco J. Sánchez-Rivera et al. NATURE
- Improved vectors and genome-wide libraries for CRISPR screening
- (2014) Neville E Sanjana et al. NATURE METHODS
- The pentose phosphate pathway and cancer
- (2014) Krushna C. Patra et al. TRENDS IN BIOCHEMICAL SCIENCES
- The emerging role of the Nrf2-Keap1 signaling pathway in cancer
- (2013) M. C. Jaramillo et al. GENES & DEVELOPMENT
- Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis
- (2013) Anju Singh et al. JOURNAL OF CLINICAL INVESTIGATION
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- Methylation of the KEAP1 gene promoter region in human colorectal cancer
- (2012) Naoyuki Hanada et al. BMC CANCER
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
- (2011) P. A. Konstantinopoulos et al. CANCER RESEARCH
- Single-vector inducible lentiviral RNAi system for oncology target validation
- (2011) Dmitri Wiederschain et al. CELL CYCLE
- Regulation ofKEAP1expression by promoter methylation in malignant gliomas and association with patient’s outcome
- (2011) Lucia Anna Muscarella et al. Epigenetics
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
- (2011) Gina M. DeNicola et al. NATURE
- Metabolomic Analysis and Visualization Engine for LC−MS Data
- (2010) Eugene Melamud et al. ANALYTICAL CHEMISTRY
- The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis
- (2009) Ella T. Nkhoma et al. BLOOD CELLS MOLECULES AND DISEASES
- Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
- (2009) Yoo Ri Kim et al. JOURNAL OF PATHOLOGY
- Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase
- (2009) Michel DuPage et al. Nature Protocols
- Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer
- (2008) Tatsuhiro Shibata et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started